Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 8866 AL 8880

Statins as potential disease-modifying therapy of Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis

Gonçalves OR, Nascimento AB, Soares VG, Abraham D, de Almeida Monteiro G, Freitas JLR, da Cunha Monteiro Ribeiro JP, Ribeiro BL, de Oliveira JVA, Dos Santos MAR, Telles JPM, Sekeff-Sallem F, Almeida KJ.

Acta Neurol Belg. 2025 Aug;125(4):915-922. doi: 10.1007/s13760-024-02709-4. Epub 2024 Dec 30.

The complexities in the differential diagnosis of restless legs syndrome (Willis-Ekbom disease)

Poplawska-Domaszewicz K, Rota S, Qamar MA, Chaudhuri KR.

Expert Rev Neurother. 2025 Feb;25(2):157-173. doi: 10.1080/14737175.2025.2450639. Epub 2025 Jan 14.

Parkinsonism and Bilateral Facial Palsy after Chimeric Antigen Receptor T-Cell Therapy

Wu AS, Hophing L, Gosse P, Motamed M, Bhella SD, Stewart K, Fasano A.

Mov Disord Clin Pract. 2025 Mar;12(3):371-374. doi: 10.1002/mdc3.14335. Epub 2025 Jan 9.

Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial

Ferreira JJ, Rascol O, Stocchi F, Antonini A, Moreira J, Castilla-Fernández G, Rocha JF, Holenz J, Poewe W; Epsilon Study investigators.

Eur J Neurol. 2025 Jan;32(1):e16420. doi: 10.1111/ene.16420.

A smart tool for non expert clinicians for the dissemination of the MDS criteria for progressive supranuclear palsy

Picillo M, Abate F, Canoro V, Tepedino MF, Barone P, Erro R.

Neurol Sci. 2025 May;46(5):1959-1964. doi: 10.1007/s10072-025-07996-0. Epub 2025 Jan 11.

Prospective Multicenter Evaluation of the MDS "Suggestive of PSP" Diagnostic Criteria

Quattrone A, Franzmeier N, Levin J, Petzold GC, Spottke A, Brosseron F, Falkenburger B, Prudlo J, Gasser T; DESCRIBE‐PSP Group, The ProPSP Group; Höglinger GU.

Mov Disord. 2025 Mar;40(3):526-536. doi: 10.1002/mds.30112. Epub 2025 Jan 10.

A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data

Nikolcheva T, Pagano G, Pross N, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Seppi K, Monnet A, Shariati N, Ricci B, Rutten-Jacobs L, Respondek G, Kustermann T, Taylor KI, Trundell D, Fontoura P, Doody R, Svoboda H, Bonni A; PADOVA Investigators and Prasinezumab Study Group.

Parkinsonism Relat Disord. 2025 Mar;132:107257. doi: 10.1016/j.parkreldis.2024.107257. Epub 2024 Dec 29.

Deterioration of preexisting myoclonus following nifedipine use in parkinsonian syndrome: A case report

Yamada G, Toyoda T, Katada E, Matsukawa N.

eNeurologicalSci. 2024 Dec 15;38:100545. doi: 10.1016/j.ensci.2024.100545. eCollection 2025 Mar.

New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease

Liang M, Chu L, Yue Z.

Mov Disord. 2025 Mar;40(3):431-437. doi: 10.1002/mds.30097. Epub 2025 Jan 15.

Plasma alpha-synuclein predicts cognitive impairment in Parkinson's disease: a systematic review and meta-analysis

Zhu Z, Cordato D, Chen R, Xu YH, Shulruf B, Chan DKY.

J Neurol. 2025 Jan 15;272(2):124. doi: 10.1007/s00415-024-12871-7.

Gamma knife versus linear accelerator thalamotomy for essential tremor and Parkinson's disease: A systematic review and meta-analysis

Chintapalli R, Chang S, Kaprealian T, Savjani R, Tenn S, Bari A.

J Clin Neurosci. 2025 Mar;133:111050. doi: 10.1016/j.jocn.2025.111050. Epub 2025 Jan 16.

Changes in sensor recorded activity patterns and neuropsychiatric symptoms after deep brain stimulation for Parkinson's disease: 5 case reports

Bruhin LC, Single M, Naef AC, Petermann K, Sousa M, Castelli M, Debove I, Maradan-Gachet ME, Magalhães AD, Diamantaras AA, Lachenmayer ML, Tinkhauser G, Waskönig J, El Achkar CM, Lemkaddem A, Lemay M, Krack P, Nef T, Amstutz D.

BMC Neurol. 2025 Jan 17;25(1):25. doi: 10.1186/s12883-025-04030-w.

Response to the letter "Reassessing the hypothesis of essential tremor as a prodromal feature of Parkinson's disease"

Yilmaz AY, Jankovic J.

Parkinsonism Relat Disord. 2025 Mar;132:107280. doi: 10.1016/j.parkreldis.2025.107280. Epub 2025 Jan 12.

Essential Tremor Suppression with a Novel Anti-Tremor Orthosis: A Randomized Crossover Trial

Mugge W, Elstgeest LEM, van Ginkel M, Pol L, de Lange I, Pambakian N, Assis de Souza A, Helmich RC, Kamphuis DJ.

Mov Disord. 2025 Mar;40(3):445-455. doi: 10.1002/mds.30082. Epub 2025 Jan 21.

Fast micrographia and frontal lobe dysfunction post-traumatic brain injury: insights into pacing impairment and rehabilitation strategy

Fukui J, Yamaga T, Anmoto N, Inagaki A.

BMJ Case Rep. 2025 Jan 21;18(1):e262065. doi: 10.1136/bcr-2024-262065.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias